文献速递脊柱关节炎

银屑病对中轴型与外周型脊柱关节炎临床表现及疾病负担的影响:REGISPONSER登记研究

Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

基于西班牙REGISPONSER登记中2296例符合ESSG标准的脊柱关节炎患者,按有无银屑病及中轴/外周表型分组比较。银屑病在中轴型中与HLA-B27+、葡萄膜炎、滑膜炎、指炎及csDMARDs使用独立相关,在外周型中与发病年龄更高、HLA-B27+及足跟附着点炎独立相关;银屑病患者患者报告结局评分更高且治疗使用更多。

要点

  • 中轴型SpA合并银屑病者HLA-B27+和葡萄膜炎更少,滑膜炎、指炎及csDMARDs使用更多。
  • 外周型SpA合并银屑病者发病年龄更高,HLA-B27+和足跟附着点炎更少。
  • 无论中轴或外周表型,银屑病均与更高的患者报告结局评分和更多治疗使用相关。

核心结论

  • 在SpA患者中,银屑病与不同的临床表达、更大的疾病负担及更多的药物使用相关。

研究设计与样本

  • 基于西班牙REGISPONSER登记,纳入按ESSG标准分类的SpA患者2296例,按有无皮肤或甲银屑病及中轴/外周表型分组,进行配对单变量和多变量分析并调整治疗摄入。

主要发现

  • 中轴型表型中,银屑病与HLA-B27+(OR 0.27)、葡萄膜炎(OR 0.46)、曾发生滑膜炎(OR 2.59)、指炎(OR 2.78)及csDMARDs使用(OR 1.47)独立相关(P < 0.05)。
  • 外周型表型中调整csDMARD摄入后,银屑病与发病年龄更高(OR 1.05)、HLA-B27+(OR 0.14)及足跟附着点炎(OR 0.22)独立相关。
  • 银屑病合并中轴型或外周型表型的患者,患者报告结局评分更高且研究访视时治疗使用更多。

关键数值与推荐

  • SpA按ESSG标准分类;中轴表型定义为存在放射学骶髂关节炎或炎性背痛,外周表型定义为无放射学骶髂关节炎且无炎性背痛但存在外周受累。

临床怎么用

  • 评估SpA患者时应关注银屑病的存在,其与不同的临床特征、更高的疾病负担及更多的治疗使用相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate whether the presence of psoriasis influences the clinical expression, disease activity and disease burden in both axial and peripheral phenotypes of spondyloarthritis (SpA). METHODS: Patients from the Spanish REGISPONSER registry classified as having SpA according to the ESSG criteria were included. Patients were classified as psoriatic or non-psoriatic depending on the presence of cutaneous or nail psoriasis; thereafter, they were classified as having either axial [presence of radiographic sacroiliitis OR inflammatory back pain (IBP)] or peripheral phenotype (absence of radiographic sacroiliitis AND absence of IBP AND presence of peripheral involvement). Pair-wise univariate and multivariate analyses among the four groups (psoriatic/non-psoriatic axial phenotypes and psoriatic/non-psoriatic peripheral phenotypes) were performed with adjustment for treatment intake. RESULTS: A total of 2296 patients were included in the analysis. Among patients with axial phenotype, psoriasis was independently associated (P < 0.05) with HLA-B27+ [odds ratio (OR) 0.27], uveitis (OR 0.46), synovitis (ever) (OR 2.59), dactylitis (OR 2.78) and the use of conventional synthetic DMARDs (csDMARDs) (OR 1.47) in comparison with non-psoriatic patients. Among patients with peripheral phenotype and adjusting for csDMARD intake, psoriasis was independently associated with higher age at disease onset (OR 1.05), HLA-B27+ (OR 0.14) and heel enthesitis (OR 0.22). Higher scores for patient-reported outcomes and greater use of treatment at the time of the study visit were observed in psoriatic patients with either axial or peripheral phenotype. CONCLUSION: These findings suggest that, among all patients with SpA, psoriasis is associated with differences in clinical expression of SpA, a greater disease burden and increased use of drugs.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. López-Medina C, Ortega-Castro R, Castro-Villegas MC, et al. Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry. Rheumatology (Oxford). 2021. PMID: 32856083. doi:10.1093/rheumatology/keaa398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。